Adiponectin has important potential in regulating inflammatory responses which are associated with the modulation of cardiovascular diseases (e.g. coronary artery disease, heart failure and atrial fibrillation), type 2 diabetes, cerebral ischemia and osteoporosis25–31. Here, ADIPOQ is linked to heart failure.